What Magentiq Eye Ltd does

Magentiq Eye Ltd is an Israel-based medical device company founded in 2014 that develops MAGENTIQ-COLO™, a software platform providing AI-augmented decision support during colonoscopy procedures. The product applies deep-learning models to the live video stream from standard endoscopy towers, performing real-time computer-aided detection (CADe) of colorectal polyps, computer-aided diagnosis (CADx) for polyp size estimation and characterization, and computer-aided quality (CAQ) metrics such as Boston Bowel Preparation Score assessment and automated cecum detection. Training data covers 65+ million frames drawn from 3,500+ full procedure videos, and pivotal validation was published in The Lancet Digital Health based on a 950+ patient randomized multicenter trial across ten centers in Europe, the US, and Israel.

MAGENTIQ-COLO is regulated as a Class II medical device, holding CE Mark since 2021, FDA 510(k) clearance since 2023, and ISO 13485:2016 certification. The platform integrates with the four leading endoscopy equipment vendors (Olympus, Fujinon, Pentax, Sonoscape) and ships in two hardware form factors (processor-only and portable on-cart). The company monetizes through a monthly rental subscription model, with additional revenue tied to procedure volume where reimbursement structures reward higher adenoma detection.

Commercially, Magentiq pursues a hybrid go-to-market: direct enterprise field sales in Europe and the United States layered on top of an exclusive US distribution agreement with PENTAX Medical (HOYA Group) that went live in October 2024. Customers are gastroenterology clinics, hospitals, and healthcare systems conducting colorectal cancer screening. Following a Series A round in July 2025 led by aMoon, the company is scaling US and European salesforce and broadening the platform into procedural quality documentation following the January 2026 release of tool detection and CAQ features.

Name

Magentiq Eye Ltd

Legal name

MAGENTIQ EYE Ltd.

Website

https://magentiq.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an FDA-cleared and CE-marked AI platform that performs real-time polyp detection, characterization, and quality documentation during colonoscopy, serving gastroenterology clinics and hospitals in Europe, the United States, and Israel via a monthly rental subscription model.

Ownership category

akta.pro rank

Product category

Gastroenterology AI Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industry

Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing) (HLAHADAD)

Keywords

• AI colonoscopy software
• Polyp detection system
• Computer-aided detection
• Gastroenterology AI platform
• Medical imaging AI

Headquarters

HQ city

Haifa

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

1. Monthly Rental Software Model: Software as a service model with monthly rental pricing. Low upfront cost with always-updated software and flexible commitment terms. Hardware options include processor-only unit or fully equipped portable cart.
2. Procedure-Based Revenue: Additional income from more colonoscopies performed and more adenomas resected. In US and some European countries, medical centers are reimbursed further if polyps are resected.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

Core offering

Magentiq Eye Ltd develops MAGENTIQ-COLO™, an AI-powered software platform that performs real-time computer-aided detection (CADe) and computer-aided diagnosis (CADx) of polyps during colonoscopy procedures. The system acquires video output from existing endoscopy towers (Olympus, Fujinon, Pentax, Sonoscape), highlights suspicious lesions with bounding boxes, and adds automated quality metrics. It is sold as a monthly-rental subscription to gastroenterology departments of hospitals and clinics, with optional hardware (processor-only unit or portable cart).

Product overview

Magentiq Eye Ltd offers a single unified product platform called MAGENTIQ-COLO™ for AI-powered gastroenterology diagnostics. The platform provides computer-aided detection (CADe) for real-time polyp detection, computer-aided diagnosis (CADx) for polyp characterization and size estimation, and computer-aided quality (CAQ) metrics for procedural documentation. The system is available in two regulatory versions: an FDA-cleared version for the U.S. market with tool detection, and a CE-marked version for Europe with additional quality features including BBPS assessment and automated cecum detection. The product integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape) and operates via a monthly rental business model.

Differentiator

Problem solved

Functional benefit

Brands

• MAGENTIQ-COLO™: AI-powered colonoscopy platform with computer-aided detection (CADe) for real-time polyp detection and computer-aided diagnosis (CADx) capabilities supporting polyp size estimation and characterization.

Products and services

• MAGENTIQ-COLO™ AI-aided colonoscopy software platform that performs real-time polyp detection and analysis during colonoscopy procedures. It integrates with major endoscopy systems (Olympus, Fujinon, Pentax, Sonoscape), highlights suspected polyps with bounding boxes on the procedure screen, and provides automated polyp size estimation, characterization, and procedural quality metrics (BBPS, cecum detection). It is targeted at gastroenterology departments in hospitals and clinics.

Quantifiable outcome

• 26% relative increase in adenoma detection rate (ADR)
• +5 more outcomes

Named customers8 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability8 records

Feature6 records

Partnerships

One partnership is on record.

• PENTAX Medical (HOYA Group)coreChannel Partner/ Reseller/ Distributor · 18 May 2024HOYA Group company PENTAX Medical announced partnership intention with MAGENTIQ EYE to distribute MAGENTIQ-COLO AI-assisted lesion detection device in the US market. Formal agreement expected with distribution beginning October 1, 2024. System demonstrated at DDW in Washington DC. Partnership in field of AI in Gastroenterology with further collaboration and strategic partnerships to be examined.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Medtronic: Medtronic distributes the GI Genius AI polyp detection system (acquired from Cosmo Pharmaceuticals) — the most direct and best-capitalized competitor to MAGENTIQ-COLO in AI-aided colonoscopy, serving the same gastroenterology customer base with similar CADe functionality.
• Iterative Health: Iterative Health is a venture-backed digital health company applying AI/ML to gastroenterology, including polyp detection and procedure quality — directly comparable in stage, AI-in-GI focus, and clinical validation approach to Magentiq.
• Satisfai Health: Satisfai Health develops AI applications for real-time polyp detection and characterization during colonoscopy and other GI procedures — a direct competitor in the same CADe/CADx clinical workflow and customer segment.

Broad incumbents

• Fujifilm Healthcare: Fujifilm is one of the four major endoscopy system manufacturers (alongside Olympus, Pentax, Sonoscape) and offers its own AI colonoscopy feature (CAD EYE) integrated into its endoscopy towers — making it both a compatible integration partner and a competing AI vendor.
• Olympus Corporation: Olympus is the largest global endoscopy system manufacturer and is also Magentiq's largest compatible-integration partner. Olympus has invested in AI endoscopy features, positioning it as a broad incumbent that could either compete with or accelerate third-party AI like MAGENTIQ-COLO.
• HOYA (Pentax Medical): HOYA's Pentax Medical is Magentiq's exclusive US distribution partner and one of the four major endoscopy OEMs. As a broad incumbent, Pentax also pursues its own AI endoscopy initiatives, creating a partnership/competitive duality.
• NEC Corporation: NEC has a medical AI business that includes computer-aided detection and diagnostic imaging solutions for endoscopy and colonoscopy. As a broad incumbent in medical AI, NEC represents both a competitor and a potential partner for hospital-wide AI deployments.

Emerging players

• Virgo Surgical Video Solutions: Virgo applies AI to endoscopic video for data capture, procedure analysis, and clinical decision support in GI procedures — overlapping thematically with Magentiq's quality-metrics and structured-reporting features (BBPS, cecum detection).
• Wision AI: Wision AI develops AI-based polyp detection software for colonoscopy and is pursuing regulatory clearances for global markets — a comparable CADe pure-play competitor, though with a regional focus on China and select international markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/magentiqeye
• LinkedInlinkedin.com/company/magentiq-eye-ltd.
• Facebookfacebook.com/Magentiq.Eye

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds13 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Magentiq Eye Ltd